Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients during abiraterone/enzalutamide treatment-Reference-Cited by-同舟云学术

Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients during abiraterone/enzalutamide treatment

Published:2021-04-27 Issue:9 Volume:81 Page:543-552
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Onal Cem¹^ORCID,Kose Fatih²,Ozyigit Gokhan³,Aksoy Sercan⁴,Oymak Ezgi⁵,Muallaoglu Sadik⁶,Guler Ozan C.¹,Tilki Burak³,Hurmuz Pervin³,Akyol Fadil³

Affiliation:

1. Department of Radiation Oncology, Faculty of Medicine, Baskent University Adana Dr. Turgut Noyan Research and Treatment Center Adana Turkey

2. Division of Medical Oncology, Faculty of Medicine, Baskent University Adana Dr. Turgut Noyan Research and Treatment Center Adana Turkey

3. Department of Radiation Oncology, Faculty of Medicine Hacettepe University Ankara Turkey

4. Division of Medical Oncology, Faculty of Medicine Hacettepe University Ankara Turkey

5. Division of Radiation Oncology Iskenderun Gelisim Hospital Iskenderun Hatay Turkey

6. Division of Medical Oncology Iskenderun Gelisim Hospital Iskenderun Hatay Turkey

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24132

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial

3. Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

4. Characterising the castration-resistant prostate cancer population: a systematic review

5. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer;Radiotherapy and Oncology;2024-07

2. The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer;Prostate Cancer and Prostatic Diseases;2024-06-19

3. Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib;Clinical and Translational Radiation Oncology;2024-05

4. Response to “Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients – A closer inspection will improve your vision”;Clinical and Translational Radiation Oncology;2024-05

5. Metastasis-Directed Stereotactic Body Radiotherapy in Prostate Cancer Patients Treated with Systemic Therapy and Undergoing Oligoprogression: Report on 11 Consecutive Cases;Radiation;2024-04-12